To predict the level of immune infiltration and improve the efficacy of immunotherapy for PDAC, we explored how PDGFRA expression influences the tumor immune microenvironment with data from public cancer sequencing databases and validated our findings in 79 PDAC samples from Fudan University Shanghai Cancer Center (FUSCC). Here, PDGFRA is linked to cancer.